Twist Bioscience Corporation
TWST
Rang in aandelen
#2208
Twist Bioscience Corporation operates as a leading synthetic biology firm,... Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthesis platform that facilitates the creation of artificial DNA by "writing" it directly onto silicon chips. Its extensive product catalog encompasses custom synthetic genes, specialized tools designed for sample preparation, comprehensive antibody libraries essential for pharmaceutical research and development, and advanced applications leveraging DNA for digital data storage. Twist Bioscience has established strategic collaborations with several organizations, including Victorian Clinical Genetic Services, Vivlion GmbH, Kyowa Kirin Pharmaceutical Research, Inc., deepCDR Biologics AG, and Centogene N.V., with the shared goal of innovating advanced sequencing technologies. Furthermore, the company engages in a research alliance with Boehringer Ingelheim International GmbH, where it applies its exclusive antibody libraries to identify and develop therapeutic antibodies against a multitude of targets. The corporation was founded in 2013 and is headquartered in South San Francisco, California.
Aandeelprijs
$140.67
Marktkapitalisatie
$9.26B
Verandering (1 dag)
5.97%
Verandering (1 jaar)
399.54%
Land
US
Handel Twist Bioscience Corporation (TWST)
Categorie
Healthcare
EPS voor Twist Bioscience Corporation (TWST)
EPS per June 2026 TTM: $-2.22
Volgens de laatste financiële rapporten en de aandelenkoers van Twist Bioscience Corporation is de huidige EPS van het bedrijf (TTM) $-2.22. Eind 2024 had het bedrijf een EPS van $-3.60, gelijk aan de EPS van 2023 die $-3.60 bedroeg.
EPS-geschiedenis van Twist Bioscience Corporation van 2016 tot 2026
EPS aan het einde van elk jaar
| Jaar | EPS | Wijzigen |
|---|---|---|
| 2026 (TTM) | $-2.22 | 70.77% |
| 2025 | $-1.30 | -63.89% |
| 2024 | $-3.60 | 0.00% |
| 2023 | $-3.60 | -10.89% |
| 2022 | $-4.04 | 28.25% |
| 2021 | $-3.15 | -11.76% |
| 2020 | $-3.57 | -8.93% |
| 2019 | $-3.92 | 46.27% |
| 2018 | $-2.68 | -15.19% |
| 2017 | $-3.16 | 34.47% |
| 2016 | $-2.35 | 0.00% |
EPS van vergelijkbare bedrijven of concurrenten
| Bedrijf | EPS | EPS-verschil | Land |
|---|---|---|---|
| $18.62 | -938.74% |
US
|
|
| $5.65 | -354.50% |
US
|
|
| $-1.36 | -38.74% |
US
|
|
| - | - |
CN
|
|
| $5.09 | -329.28% |
US
|
